Home
Clinical Trials
Renal Anemia Refractory to Er...

Renal Anemia Refractory to Erythropoietin

Last Updated: 2019-01-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-31

Study Completion Date

2019-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the renal anemia refractory to Epo . in hemodialysis patients. all of participants will receive Epo. and identify various factors contributing to etiology of renal anemia in Epo- resistant patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients

NCT00701714

Anemia Chronic Renal Insufficiency

TERMINATED PHASE3

Prevalence of Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis Patients in Assiut University Hospital

NCT06053866

Erythropoietin Resistant Anemia (EPO Resistant Anemia)

NOT_YET_RECRUITING

Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'

NCT02341547

End Stage Renal Failure Anaemia

UNKNOWN

Erythropoietin Resistance in Anemia of Chronic Kidney Disease

NCT00526747

Anemia Kidney Failure Erythropoietin

COMPLETED

Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure

NCT00391287

Pure Red-Cell Aplasia Chronic Kidney Failure

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic kidney disease (CKD) is considered a public health problem worldwide with high incidence and prevalence rates.Anemia is one of the most frequent early complication of CKD. The main cause is erythropoietin (EPO) deficiency due to impaired kidney function However, other causes should be considered when the severity of anemia is inconsistent with the decrease in renal function; when there is evidence of iron deficiency or matching decreases in hemoglobin, leukopenia and/or thrombocytopenia are also found

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ESRD Renal Anemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients greater than or equal to 18 years old with CKD on hemodialysis

Exclusion Criteria

1. \- Evidence of infections especial of vascular access .
2. \- malnutrition and manifestation of iron, B12, folate and protein deficiency .
3. \- any underling cause as;

* Hematologic malignances -Hemolytic anemia -
* Aplastic anemia (infection and/or bleeding with anemia)
* Solid tumors
* Bleeding (skin ,mucosal ,orificial)
* Evidence of mineral bone disease (CKD-MBD)
* Others

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers